EUVIMEDEUVIMED entdecken
Crossref

Phage proteases activate CBASS antiphage immunity

Samuel J Hobbs iD, Philip J Kranzusch iD

Science · 2026

DOI: 10.1126/science.aeg3949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2026. Verfasst von Samuel J Hobbs und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Bacteriophage T4, Nucleotidyltransferases, Viral Proteins, Endopeptidases. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Institutes of Health, Burroughs Wellcome Fund, Pew Charitable Trusts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic oligonucleotide–based antiphage signaling systems (CBASS) are bacterial immune pathways evolutionarily related to cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) in humans. In CBASS, cGAS/DncV-like nucleotidyltransferase (CD-NTase) enzymes sense phage infection and synthesize nucleotide signals to initiate antiviral defense. Here, we reveal phage prohead protease activity as a widespread mechanism of CD-NTase activation. We reconstitute CBASS recognition of phage T4 in vitro and identify proteolytic cleavage of a CD-NTase activation loop as a trigger of immune signal synthesis. Phage prohead proteases directly activate CBASS in vivo, explaining how immunity is initiated late during infection. Structure-based phylogenetic analyses identify activation loops in clade A, D, and G CD-NTases and define residues controlling recognition of distinct phage families. Our results establish CBASS recognition of phage protease activity as a widespread antiviral defense mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacteriophage T4NucleotidyltransferasesViral ProteinsEndopeptidasesEscherichia colicGAS-STING Signaling PathwayPhylogenyProteolysisSignal Transduction

Substanzen

NucleotidyltransferasesViral Proteinsgp21 morphogenetic proteinase, phage T4Endopeptidases

Autor:innen und Institutionen

  • Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, USA.

ORCID-Profile: Samuel J Hobbs, Philip J Kranzusch

Förderung

  • National Institutes of Health
  • Burroughs Wellcome Fund
  • Pew Charitable Trusts
  • Cancer Research Institute
  • G. Harold and Leila Y. Mathers Foundation
  • Parker Institute for Cancer Immunotherapy
  • Massachusetts Consortium on Pathogen Readiness
  • Cancer Research Institute Irvington Postdoctoral Fellowship

Zitieren

APA

Hobbs, S. J., & Kranzusch, P. J. (2026). Phage proteases activate CBASS antiphage immunity. Science. https://doi.org/10.1126/science.aeg3949

Vancouver

Hobbs SJ, Kranzusch PJ. Phage proteases activate CBASS antiphage immunity. Science. 2026. doi:10.1126/science.aeg3949

BibTeX
@article{Hobbs2026,
  author = {Hobbs, Samuel J and Kranzusch, Philip J},
  title = {Phage proteases activate CBASS antiphage immunity},
  journal = {Science},
  year = {2026},
  doi = {10.1126/science.aeg3949}
}
Kostenlos starten →